Neil W. Gibson
2012
In 2012, Neil W. Gibson earned a total compensation of $927.2K as Chief Scientific Officer at Regulus Therapeutics, a 70% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $107,950 |
|---|---|
| Option Awards | $481,351 |
| Salary | $332,153 |
| Other | $5,729 |
| Total | $927,183 |
Gibson received $481.4K in option awards, accounting for 52% of the total pay in 2012.
Gibson also received $108K in non-equity incentive plan, $332.2K in salary and $5.7K in other compensation.
Rankings
In 2012, Neil W. Gibson's compensation ranked 6,435th out of 11,487 executives tracked by ExecPay. In other words, Gibson earned more than 44.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,435 out of 11,487 | 44th |
Division Manufacturing | 2,307 out of 4,253 | 46th |
Major group Chemicals And Allied Products | 581 out of 1,198 | 52nd |
Industry group Drugs | 396 out of 920 | 57th |
Industry Pharmaceutical Preparations | 310 out of 700 | 56th |
Source: SEC filing on April 30, 2013.
Gibson's colleagues
We found two more compensation records of executives who worked with Neil W. Gibson at Regulus Therapeutics in 2012.